MEDCATH CORP: 10-K filed 2011-12-14
What MEDCATH CORP reported in its annual report filed 2011-12-14 (fiscal FY 2011): 24 published measures, 69 facts as tagged in accession 0001193125-11-341025.
This filing
- Form
- 10-K (annual report)
- Filed
- 2011-12-14
- Fiscal period
- fiscal FY 2011
- Accession
- 0001193125-11-341025 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDCATH CORP filings.
Reported measures
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-22 | 201,214,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-22 | 225,754,000 | USD | |
| At 2010-09-30 | 23,208,000 | USD | |
| At 2009-09-30 | 14,436,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 66,636,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | -48,371,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -50,282,000 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | -28,131,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | 43,294,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | 63,633,000 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 1,857,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | 11,616,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | 78,108,000 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | -177,357,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | -41,009,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -50,210,000 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 435,394,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | -16,956,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -63,790,000 | USD | 365 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 20,153 | shares | 357 |
| 2009-10-01 to 2010-09-30 | 19,842 | shares | 365 |
| 2008-10-01 to 2009-09-30 | 19,684 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 20,159 | shares | 357 |
| 2009-10-01 to 2010-09-30 | 19,842 | shares | 365 |
| 2008-10-01 to 2009-09-30 | 19,684 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 3.3 | USD/shares | 357 |
| 2009-10-01 to 2010-09-30 | -2.44 | USD/shares | 365 |
| 2008-10-01 to 2009-09-30 | -2.55 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 3.3 | USD/shares | 357 |
| 2009-10-01 to 2010-09-30 | -2.44 | USD/shares | 365 |
| 2008-10-01 to 2009-09-30 | -2.55 | USD/shares | 365 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | -16,963,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | -33,377,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -7,581,000 | USD | 365 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 4,311,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | 3,148,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | 2,390,000 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | -56,826,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | -90,052,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -26,669,000 | USD | 365 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 2,320,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | 3,935,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | 3,053,000 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 20,469,305 | shares |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-22 | 213,121,000 | USD | |
| At 2010-09-30 | 282,470,000 | USD | |
| At 2009-09-30 | 337,082,000 | USD | |
| At 2008-09-30 | 385,219,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | -42,360,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | -90,049,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -30,975,000 | USD | 365 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 129,345,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | -35,982,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -32,755,000 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 8,014,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | 12,221,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | 7,476,000 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 14,466,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | 3,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -4,306,000 | USD | 365 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 19,863,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | -22,982,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | -3,322,000 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | 26,294,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | 26,032,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | 12,812,000 | USD | 365 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-10-01 to 2011-09-22 | -282,000 | USD | 357 |
| 2009-10-01 to 2010-09-30 | 496,000 | USD | 365 |
| 2008-10-01 to 2009-09-30 | 1,712,000 | USD | 365 |
Inspect the source
- Entity
- MEDCATH CORP / CIK 0001139463
- Captured
- SEC response SHA-256
3b6d4dfa41bb98f62916f6d82c765aed3c96a7f75f95e624b948ebd688343f4b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001139463.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))